Sep 12
|
CDC advisers recommend Covid vaccine boosters for kids & adults
|
Sep 12
|
FDA Approves Pfizer & Moderna's New COVID Booster Vaccines
|
Sep 12
|
UPDATE 6-US CDC recommends broad use of updated COVID-19 vaccines
|
Sep 12
|
US CDC contemplates who should get the new COVID shots
|
Sep 11
|
Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters
|
Sep 11
|
US approval of fall boosters comes amid uptick in COVID-19 cases
|
Sep 11
|
FDA authorizes updated Covid-19 vaccines, with CDC sign-off to come soon
|
Sep 8
|
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
|
Sep 8
|
Novavax to Participate in Upcoming September Conferences
|
Sep 7
|
U.S. First Lady Tests Positive for COVID as Cases Spike — Is It Time to Jump Back Into Vaccine Stocks?
|
Sep 7
|
Novavax (NVAX) Up 36.8% Since Last Earnings Report: Can It Continue?
|
Sep 7
|
Moderna (MRNA) Updated COVID Jab Effective Against Pirola Variant
|
Sep 7
|
7 Biotech Stocks to Sell in September Before They Crash & Burn
|
Sep 6
|
Stocks on the Mend: A Mean Reversion Duo
|
Sep 6
|
Novavax Inc (NVAX): A Deep Dive into Its Performance Potential
|
Aug 11
|
2 Beaten-Down Stocks That Still Aren't Worth Buying
|
Aug 10
|
Why Novavax Stock Blasted 8% Higher Today
|
Aug 9
|
Novavax (NVAX) Q2 Earnings Beat, Stock Down 4% on '23 Sales Cut
|
Aug 8
|
Novavax stock closes lower despite Q2 earnings beat
|
Aug 8
|
Novavax reports surprise Q2 profit but reiterates 'going concern' warning
|